Evidence map›Paper›PMID 26962942›Full record

ArticleCell host & microbe2016

Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.

Cynthia L Monaco, David B Gootenberg, Guoyan Zhao, Scott A Handley, Musie S Ghebremichael, Efrem S Lim, Alex Lankowski, Megan T Baldridge, Craig B Wilen, Meaghan Flagg and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 277 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
277citing papers in PubMed, 4 pooled it
24.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

277 citing papers in PubMed, 4 syntheses or guidelines pooled it, 436 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The Impact of Human Immunodeficiency Virus Infection on Gut Microbiota α-Diversity: An Individual-level Meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

217 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 2 countries.

Cynthia L MonacoDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
David B GootenbergRagon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
Guoyan ZhaoDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Scott A HandleyDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Musie S GhebremichaelRagon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
Efrem S LimDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Alex LankowskiDivision of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Megan T BaldridgeDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Craig B WilenDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Meaghan FlaggRagon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
Jason M NormanVedanta Biosciences, Cambridge, MA 02139, USA.
Brian C KellerDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Jesús Mario LuévanoRagon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
David WangDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Yap BoumMédecins Sans Frontières Epicentre, 1956 Mbarara, Uganda.
Jeffrey N MartinDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94143, USA.
Peter W HuntDepartment of Medicine, University of California San Francisco, San Francisco, CA 94110, USA.
David R BangsbergDivision of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Harvard School of Public Health, Boston, MA 02114, USA.
Mark J SiednerDivision of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Douglas S KwonRagon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. Electronic address: dkwon@mgh.harvard.edu.
Herbert W VirginDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA. Electronic address: virgin@wustl.edu.
Washington University in St. Louis · USRagon Institute of MGH, MIT and Harvard · USMassachusetts General Hospital · USUniversity of California, San Francisco · USHarvard University · USMédecins Sans Frontières · UGVedantra Pharmaceuticals (United States) · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
AIDS and Cancer Specimen Resource (ACSR)UM1CA181255 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jeffrey Michael Bethony, Anna Coghill · 2013 to 2026
$56.7M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
TB PREVENTION AND HIV IN THE HOMELESS--AN INTERVENTIONR01MH054907 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 1995 to 2014
$20.7M
PRINCIPLES IN PULMONARY RESEARCHT32HL007317 · NHLBI · WASHINGTON UNIVERSITY · PI Steven Brody, Michael J Holtzman · 1985 to 2026
$16.1M
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
RESEARCH TRAINING IN DIGESTIVE DISEASES AND NUTRITIONT32DK007191 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1986 to 2026
$14.6M
Infectious Diseases/Basic Microbial Pathogenic MechanismsT32AI007172 · NIAID · WASHINGTON UNIVERSITY · PI Daniel E. Goldberg, JENNIFER A PHILIPS · 1985 to 2026
$13.0M
TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCERT32CA009547 · NCI · WASHINGTON UNIVERSITY · PI ROBERT DAVID SCHREIBER · 1986 to 2026
$12.1M
The enteric microbiome in treated and progressive HIV infectionR01DK101354 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KWON, DOUGLAS, VIRGIN, HERBERT W · 2014 to 2018
$3.7M
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1TR000448NCI NIH HHS 5T32CA009547NCI NIH HHS P30 CA091842NCI NIH HHS P30 CA91842NCI NIH HHS T32 CA009547NCI NIH HHS UM1 CA181255NHLBI NIH HHS R21 HL124712NHLBI NIH HHS R21 HL124712-01NHLBI NIH HHS T32 HL007317NHLBI NIH HHS T32 HL007317-36NIAID NIH HHS 2P30 AI060354NIAID NIH HHS 5T32AI007163-35NIAID NIH HHS 5T32AI007172-34NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI111918NIAID NIH HHS T32 AI007163NIAID NIH HHS T32 AI007172NIDDK NIH HHS R01 DK101354NIDDK NIH HHS T32 DK007191NIDDK NIH HHS T32DK007191NIH HHS R01 OD011170NIH HHS R24 OD019793NIMH NIH HHS K23 MH099916NIMH NIH HHS R01 MH054907NIMH NIH HHS R01 MH54907PHS HHS R24 ODO19793
6 · The paper itself

Abstract

Human immunodeficiency virus (HIV) infection is associated with increased intestinal translocation of microbial products and enteropathy as well as alterations in gut bacterial communities. However, whether the enteric virome contributes to this infection and resulting immunodeficiency remains unknown. We characterized the enteric virome and bacterial microbiome in a cohort of Ugandan patients, including HIV-uninfected or HIV-infected subjects and those either treated with anti-retroviral therapy (ART) or untreated. Low peripheral CD4 T cell counts were associated with an expansion of enteric adenovirus sequences and this increase was independent of ART treatment. Additionally, the enteric bacterial microbiome of patients with lower CD4 T counts exhibited reduced phylogenetic diversity and richness with specific bacteria showing differential abundance, including increases in Enterobacteriaceae, which have been associated with inflammation. Thus, immunodeficiency in progressive HIV infection is associated with alterations in the enteric virome and bacterial microbiome, which may contribute to AIDS-associated enteropathy and disease progression.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaAcquired Immunodeficiency SyndromeAnti-Retroviral AgentsBacteriaCD4-Positive T-LymphocytesGenetic VariationHealthy VolunteersHIV EnteropathyHumansPhylogenyUgandaVirusesAnti-Retroviral AgentsadenovirusAIDSAIDS enteropathyHIVmicrobiomesystemic inflammationvirome

Identifiers

PMID26962942
PMCPMC4821831
OpenAlexW2296527675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.